DURECT Management
Management criteria checks 2/4
DURECT's CEO is Jim Brown, appointed in Feb 1998, has a tenure of 25.67 years. total yearly compensation is $1.51M, comprised of 38% salary and 62% bonuses, including company stock and options. directly owns 0.81% of the company’s shares, worth €189.43K. The average tenure of the management team and the board of directors is 6.1 years and 4.8 years respectively.
Key information
Jim Brown
Chief executive officer
US$1.5m
Total compensation
CEO salary percentage | 38.0% |
CEO tenure | 26yrs |
CEO ownership | 0.8% |
Management average tenure | 6.1yrs |
Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$37m |
Jun 30 2023 | n/a | n/a | -US$36m |
Mar 31 2023 | n/a | n/a | -US$36m |
Dec 31 2022 | US$2m | US$575k | -US$35m |
Sep 30 2022 | n/a | n/a | -US$32m |
Jun 30 2022 | n/a | n/a | -US$39m |
Mar 31 2022 | n/a | n/a | -US$37m |
Dec 31 2021 | US$1m | US$555k | -US$36m |
Sep 30 2021 | n/a | n/a | -US$38m |
Jun 30 2021 | n/a | n/a | -US$37m |
Mar 31 2021 | n/a | n/a | -US$14m |
Dec 31 2020 | US$1m | US$539k | -US$14m |
Sep 30 2020 | n/a | n/a | -US$11m |
Jun 30 2020 | n/a | n/a | -US$3m |
Mar 31 2020 | n/a | n/a | -US$24m |
Dec 31 2019 | US$1m | US$531k | -US$21m |
Sep 30 2019 | n/a | n/a | -US$24m |
Jun 30 2019 | n/a | n/a | -US$24m |
Mar 31 2019 | n/a | n/a | -US$24m |
Dec 31 2018 | US$1m | US$531k | -US$25m |
Sep 30 2018 | n/a | n/a | -US$10m |
Jun 30 2018 | n/a | n/a | -US$962k |
Mar 31 2018 | n/a | n/a | -US$4m |
Dec 31 2017 | US$1m | US$531k | -US$4m |
Compensation vs Market: Jim's total compensation ($USD1.51M) is above average for companies of similar size in the German market ($USD414.70K).
Compensation vs Earnings: Jim's compensation has increased whilst the company is unprofitable.
CEO
Jim Brown (66 yo)
26yrs
Tenure
US$1,514,025
Compensation
Dr. James E. Brown, also known as Jim, D.V.M., serves as Life Science Advisor since 2021 at K2X Technology & Life Science, Inc. He Co-founded DURECT Corporation in February 1998 and has been its President...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 26yrs | US$1.51m | 0.81% $ 189.4k | |
Senior Vice President of Operations & Corporate Quality Assurance | 9.9yrs | US$713.55k | 0.012% $ 2.7k | |
Chief Medical Officer | 3.3yrs | US$849.68k | 0.0030% $ 709.7 | |
CFO & Secretary | 1.6yrs | no data | no data | |
Interim Principal Accounting Officer | 22.8yrs | US$452.77k | no data | |
Executive VP of Research & Development and Principal Scientist | no data | no data | no data | |
Senior Vice President of Business Development | 1.4yrs | no data | no data | |
Executive Officer | 6.1yrs | US$430.63k | no data |
6.1yrs
Average Tenure
66yo
Average Age
Experienced Management: DC8's management team is seasoned and experienced (6.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 25.7yrs | US$1.51m | 0.81% $ 189.4k | |
Independent Chairman of the Board | 3.1yrs | US$86.15k | 0.067% $ 15.8k | |
Independent Director | 3.1yrs | US$81.65k | 0.020% $ 4.7k | |
Independent Director | 17.2yrs | US$83.15k | 0.010% $ 2.4k | |
Independent Director | 2.2yrs | US$72.93k | 0.023% $ 5.5k | |
Independent Director | 4.8yrs | US$79.94k | 0.12% $ 28.1k | |
Director | 4.8yrs | US$70.65k | 0.034% $ 7.9k |
4.8yrs
Average Tenure
66yo
Average Age
Experienced Board: DC8's board of directors are considered experienced (4.8 years average tenure).